Dr. Amit Kulkarni is a Medical Oncologist specializing in thoracic malignancies at the University of Minnesota, Masonic Cancer Center. He joined the faculty in 2020 after completing his fellowship at the University of Minnesota. His research is focused on evaluating the role of microbiome as a novel biomarker for treatment response. In addition, he is studying the feasibility of modulating the gut microbiome to boost treatment outcomes.
Midwest Lung Cancer Patient Summit Presentation:
Gut Microbiota Related to Lung Cancer and the Immune System – Amit Kulkarni, MD, University of Minnesota
Discuss the role of microbiome at the interface of the immune system, lung cancer development and its treatment. I will also discuss the impact of diet and medications on the gut health (microbiome) and treatment response.